Coris > CDMO
At Coris BioConcept, we offer a full-service CDMO platform tailored to in-vitro diagnostics: from development through pilot production to commercial launch. Leveraging over two decades of expertise in rapid tests (immunochromatography, electrochemistry, LAMP (isothermal amplification), ELISA) and our newly strengthened molecular portfolio, we partner with innovators worldwide to bring their assay ideas to life. Sample types may be blood, plasma/serum, urine, respiratory samples, stool, saliva, crust/pustule, bacterial cultures (colonies or liquid), blood culture,...
Coris BioConcept offers a broad range of services from concept feasibility to manufacturing, including prototype development, industrialization and regulatory support.
A company had developed an in-house ELISA assay to monitor protein production as part of its quality control procedures. However, the process was time-consuming, resourceintensive, and the assay's limited shelf life increased production and QC costs.
Coris BioConcept successfully adapted the ELISA into a lateral-flow format, achieving superior performance and a significantly extended shelf life (up to 48 months). Beyond technical transfer, Coris also supported the client in regulatory matters and now manufactures the rapid test routinely under a long-term partnership.
A diagnostic company producing a broad range of antigen and antibody ELISAs wanted to enter new markets by converting selected assays into dipstick or cassette (lateral-flow) formats. The project required rapid turnaround and scalability.
Coris BioConcept mobilized a cross-functional R&D team, completing multiple assay conversions within a few weeks. The resulting ICT assays met all performance expectations and are now manufactured unlabelled by Coris, allowing the customer to handle final branding and packaging independently.
A young innovative company (YIC) developed a promising lateral-flow prototype using benchtop equipment but lacked industrial manufacturing capabilities.
Coris BioConcept reviewed and optimized all production protocols to ensure robust, reproducible large-scale manufacturing. Pilot lots were successfully produced and final packaging completed at Coris' facility. Coris' Quality and Regulatory teams also supported the client through the registration process, ensuring compliance and readiness for market launch.